Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Jane Street Reports 22.9M Share Stake in Super Micro

Jane Street Group, LLC and affiliated entities filed Amendment No. 3 to Schedule 13G with the SEC on November 6, 2026, disclosing their beneficial ownership positions in Super Micro Computer, Inc. as of September 30, 2026.

Manish Choudhary | 06 November 2026

Joseph Gilliam Joins 10x Genomics Board, Holds 31 Shares

Director Joseph E. Gilliam filed an initial statement of beneficial ownership with the SEC on November 6, 2026, disclosing his securities holdings in 10x Genomics, Inc. as of the event date of October 28, 2026.

Nitish Kishor | 06 November 2026

Ansuman Satpathy Files Initial Ownership Form for 10x Genomics

Ansuman Satpathy, a newly appointed director of 10x Genomics, Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 6, 2026, disclosing no securities beneficially owned as of the event date of October 28, 2026.

Aakashdeep | 06 November 2026

Omada Health CEO Duffy Sells 12,944 Shares at $19.22

Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc. (NASDAQ:OMDA), filed a Form 4 on November 6, 2026, disclosing a stock option exercise and same-day sale of 12,944 shares of common stock on November 4, 2026, executed under a pre-established 10b5-1 …

Vinay Lochav | 06 November 2026

Pollard Sells 10,000 Allegiant Travel Shares at $93.04

Director Charles W. Pollard filed a Form 4 with the SEC on November 6, 2026, disclosing the sale of 10,000 shares of Allegiant Travel Co common stock on that same date.

Anjali Anand | 06 November 2026

Gogo Extends $544.4M Term Loans to October 2030

Gogo Inc. filed a current report on November 6, 2026, disclosing that it and its wholly owned subsidiary Gogo Intermediate Holdings LLC entered into a third amendment to their 2021 credit agreement, converting a portion of existing term loans into new 2026 Extended Term …

Shwetambri Chauhan | 06 November 2026

Medicus Pharma Q3 2026: CD228V Named Lead Program

Medicus Pharma Ltd. filed a Form 425 on November 6, 2026, disclosing third-quarter 2026 financial results, a co-development and license agreement with Pfizer for CD228V, a non-binding letter of intent for a proposed SkinJect SPAC business combination at approximately $135 million pre-money enterprise valuation, …

Manish Choudhary | 06 November 2026

GPGI Inc. Q3 2026 10-Q: 289.9M Shares Outstanding

GPGI, Inc. (NYSE:GPGI) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing 289,901,892 shares of Class A common stock outstanding as of November 5, 2026.

Aakashdeep | 06 November 2026

BancFirst Posts $196.9M Net Income for Nine Months Ended Sept. 30, 2026

BancFirst Corporation filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the period ended September 30, 2026, and reporting results for both the third quarter and the first nine months of the fiscal year.

Anjali Anand | 06 November 2026

abrdn Gold ETF Trust NAV Falls to $39.75 in Q3 2026

abrdn Gold ETF Trust filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 6, 2026, reporting financial results and portfolio data for the three and nine months ended September 30, 2026.

Shwetambri Chauhan | 06 November 2026
Support

Hi! How can we help you today?

Loading…